Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Hypoglycemic effects of the alpha2-adrenoceptor antagonists SL-84.0418 and deriglidole

April 20, 1998

More GH secretagogues in the pipeline at Merck & Co.

April 17, 1998

Selective beta3-adrenoceptor agonists from Merck & Co. for obesity, diabetes

April 17, 1998

Pfizer announces Viagra market introduction

April 16, 1998

Propionanilide derivatives for lipoprotein disorders discovered at Yamanouchi

April 16, 1998

Yamanouchi describes novel antidiabetic agents

April 15, 1998

Neurogen evaluates benzylamine derivatives as NPY receptor ligands

April 15, 1998

FDA approves fifth indication for Neupogen

April 14, 1998

Novartis presents new tyrosine kinase inhibitor with antiresorptive activity

April 14, 1998

Orphan Medical receives approval to market Sucraid in U.S.

April 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...